Biostage Competitors and Similar CompaniesClear all

Biostage's competitors and similar companies include Biovotion, OrthoPediatrics, Seegene and Cardiac Dimensions.

	Biostage Biostage is developing bioengineered organ implants to address unmet needs in the treatment of life-threatening esophagus, trachea and bronchus conditions.	Biovotion Biovotion is a wearable physiology monitoring company.	OrthoPediatrics OrthoPediatrics designs, develops, manufactures, and distributes orthopedic implants and instruments for pediatric orthopedic surgeons.	Seegene Seegene ((주)씨젠) is a company that manufactures molecular diagnostics products.	Cardiac Dimensions Cardiac Dimensions is a medical device company developing tools and techniques for the treatment of heart failure and related conditions.
Founding Date	Founding Date 2012	Founding Date 2011	Founding Date 2006	Founding Date 2000	Founding Date 2000
Type	Type Public	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech healthtech medical devices	Tags Technology healthtech medtech mobile app monitoring wearables	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices
Locations	Locations Holliston, US HQ	Locations Zürich, CH HQ	Locations Warsaw, US HQ	Locations Seoul, KR HQ Contagem, BR Toronto, CA Düsseldorf, DE Genova, IT Ciudad De México, MX Dubai, AE see more	Locations Kirkland, US HQ Macquarie Park, AU Offenbach Am Main, DE
Employees	Employees 14	Employees 1	Employees 9418% increase	Employees 88478% increase	Employees 653% increase
Valuation ($)	Valuation ($) 63.9 m	Valuation ($) N/A	Valuation ($) 632.7 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $704k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $236.3m (FY, 2025)	Revenue (est.) ₩474.2b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $646k (FY, 2025)	Cost of goods N/A	Cost of goods $63.7m (FY, 2025)	Cost of goods ₩133.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $58k (FY, 2025)	Gross profit N/A	Gross profit $172.7m (FY, 2025)	Gross profit ₩345b (FY, 2025)	Gross profit N/A
Net income	Net income ($6.9m) (FY, 2025)	Net income N/A	Net income ($39.6m) (FY, 2025)	Net income ₩48.4b (FY, 2025)	Net income N/A
Operating ⚠
Countries	Countries N/A	Countries N/A	Countries 36 (Nov, 2017)	Countries 48 (Q2, 2020)	Countries N/A
Distributors	Distributors N/A	Distributors N/A	Distributors 31 (Nov, 2017)	Distributors 100 (Q3, 2022)	Distributors N/A
Patents Issued	Patents Issued N/A	Patents Issued 8 (Sep, 2019)	Patents Issued 21 (Nov, 2017)	Patents Issued N/A	Patents Issued N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 13.4m	Total funding raised $ 39m	Total funding raised N/A	Total funding raised $ 178.5m